BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 24077328)

  • 1. Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.
    Mathew G; Mitchell A; Down JM; Jacobs LA; Hamdy FC; Eaton C; Rosario DJ; Cross SS; Winder SJ
    Sci Rep; 2013 Sep; 3():2792. PubMed ID: 24077328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
    Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
    J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of β-Dystroglycan in Nuclear Dynamics.
    Cook M; Stevenson B; Jacobs LA; Leocadio Victoria D; Cisneros B; Hobbs JK; Stewart CL; Winder SJ
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From adhesion complex to signaling hub: the dual role of dystroglycan.
    Sciandra F; Bozzi M; Bigotti MG
    Front Mol Biosci; 2023; 10():1325284. PubMed ID: 38155958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis.
    Quereda C; Pastor À; Martín-Nieto J
    Cancer Cell Int; 2022 Dec; 22(1):395. PubMed ID: 36494657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Duchenne muscular dystrophy gene and cancer.
    Jones L; Naidoo M; Machado LR; Anthony K
    Cell Oncol (Dordr); 2021 Feb; 44(1):19-32. PubMed ID: 33188621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Molecular Basis and Biologic Significance of the β-Dystroglycan-Emerin Interaction.
    Gómez-Monsivais WL; Monterrubio-Ledezma F; Huerta-Cantillo J; Mondragon-Gonzalez R; Alamillo-Iniesta A; García-Aguirre I; Azuara-Medina PM; Arguello-García R; Rivera-Monroy JE; Holaska JM; Hernández-Méndez JME; Garrido E; Magaña JJ; Winder SJ; Brancaccio A; Martínez-Vieyra I; Navarro-Garcia F; Cisneros B
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32824881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of Dystroglycan Drives Cellular Senescence via Defective Mitosis-Mediated Genomic Instability.
    Jimenez-Gutierrez GE; Mondragon-Gonzalez R; Soto-Ponce LA; Gómez-Monsiváis WL; García-Aguirre I; Pacheco-Rivera RA; Suárez-Sánchez R; Brancaccio A; Magaña JJ; C R Perlingeiro R; Cisneros B
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.
    Yatsenko AS; Kucherenko MM; Xie Y; Aweida D; Urlaub H; Scheibe RJ; Cohen S; Shcherbata HR
    BMC Med; 2020 Jan; 18(1):8. PubMed ID: 31959160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microstructure of laminin-111 compensates for dystroglycan loss in mammary epithelial cells in downstream expression of milk proteins.
    Kent AJ; Mayer N; Inman JL; Hochman-Mendez C; Bissell MJ; Robertson C
    Biomaterials; 2019 Oct; 218():119337. PubMed ID: 31325803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular domain of β-dystroglycan mediates the nucleolar stress response by suppressing UBF transcriptional activity.
    Azuara-Medina PM; Sandoval-Duarte AM; Morales-Lázaro SL; Modragón-González R; Vélez-Aguilera G; Gómez-López JD; Jiménez-Gutiérrez GE; Tiburcio-Félix R; Martínez-Vieyra I; Suárez-Sánchez R; Längst G; Magaña JJ; Winder SJ; Ortega A; Ramos Perlingeiro RC; Jacobs LA; Cisneros B
    Cell Death Dis; 2019 Feb; 10(3):196. PubMed ID: 30814495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy.
    Nickolls AR; Bönnemann CG
    Dis Model Mech; 2018 Dec; 11(12):. PubMed ID: 30578246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer.
    James NE; Chichester C; Ribeiro JR
    Front Oncol; 2018; 8():124. PubMed ID: 29740539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus.
    Gracida-Jiménez V; Mondragón-González R; Vélez-Aguilera G; Vásquez-Limeta A; Laredo-Cisneros MS; Gómez-López JD; Vaca L; Gourlay SC; Jacobs LA; Winder SJ; Cisneros B
    Sci Rep; 2017 Aug; 7(1):9906. PubMed ID: 28852008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as mediators of platinum resistance in ovarian cancer.
    Crow J; Atay S; Banskota S; Artale B; Schmitt S; Godwin AK
    Oncotarget; 2017 Feb; 8(7):11917-11936. PubMed ID: 28060758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression pattern in retinal photoreceptors of POMGnT1, a protein involved in muscle-eye-brain disease.
    Uribe ML; Haro C; Ventero MP; Campello L; Cruces J; Martín-Nieto J
    Mol Vis; 2016; 22():658-73. PubMed ID: 27375352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERK Signals: Scaffolding Scaffolds?
    Casar B; Crespo P
    Front Cell Dev Biol; 2016; 4():49. PubMed ID: 27303664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Secretase Dependent Nuclear Targeting of Dystroglycan.
    Leocadio D; Mitchell A; Winder SJ
    J Cell Biochem; 2016 Sep; 117(9):2149-57. PubMed ID: 26990187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dystroglycan Depletion Impairs Actin-Dependent Functions of Differentiated Kasumi-1 Cells.
    Escárcega-Tame MA; Martínez-Vieyra I; Alonso-Rangel L; Cisneros B; Winder SJ; Cerecedo D
    PLoS One; 2015; 10(12):e0144078. PubMed ID: 26630171
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.